> Skip repeated content

VIDEO: Anabasum shows acceptable safety, tolerability for diffuse system sclerosis

Healio Rheumatology—November 6, 2017

In a video interview at the American College of Rheumatology (ACR) Annual Meeting, Healio Rheumatology featured HSS rheumatologist Robert F. Spiera, MD discussing his new study and treatment for systemic sclerosis. Dr. Spiera explained that a cannabinoid-derived drug appeared to be effective in treating skin inflammation.

"This was an important study and really is going to lay the groundwork for future studies in this disease," said Dr. Spiera.

Watch the full video at healio.com [registration required].

Additional Coverage:


Need Help Finding a Physician?

Call us toll-free at:

Media Contacts


Social Media Contacts